— Know what they know.
Not Investment Advice

ACBM OTC

Acro Biomedical Co., Ltd.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +17.1% 1Y: +3614.3% 3Y: -99.3%
$0.03
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 40 · $1.6M mcap · 30M float · 0.0000% daily turnover

Balance Sheet Trends

Total Assets
$14K -55.9% ▼
5Y CAGR: -57.3%
Total Liabilities
$401K +22.7% ▲
5Y CAGR: +5.1%
Shareholders Equity
-$387K -31.2% ▼
Cash & Investments
$4K +760.9% ▲
5Y CAGR: -25.7%
Total Debt
$326K +1110.2% ▲
5Y CAGR: +67.8%
Net Debt
$321K +1116.5% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$95K$6K$376$476$4K
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$95K$6K$376$476$4K
Net Receivables$598K$638K$0$0$0
Inventory$12K$12K$0$0$0
Other Current Assets$0$0$0$5K$0
Total Current Assets$706K$658K$2K$5K$14K
Property, Plant & Equip.$50K$26K$52K$27K$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$4K$4K$5K$0$0
Total Non-Current Assets$55K$30K$57K$27K$0
Total Assets$761K$687K$58K$32K$14K
— Liabilities —
Accounts Payable$26K$77K$154K$154K$56K
Short-Term Debt$0$0$0$27K$326K
Deferred Revenue$20K$20K$20K$20K$20K
Other Current Liabilities$21K$79K$0$99K$0
Total Current Liabilities$92K$201K$289K$327K$401K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$26K$0$27K$0$0
Total Liabilities$117K$201K$315K$327K$401K
— Equity —
Common Stock$60K$60K$60K$60K$60K
Retained Earnings-$8M-$24M-$33M-$33M-$33M
Accumulated OCI-$24M-$8M$0$0$0
Total Stockholders Equity$644K$486K-$257K-$295K-$387K
Total Liabilities & Equity$761K$687K$58K$32K$14K
— Key Metrics —
Total Debt$50K$26K$52K$27K$326K
Net Debt-$45K$20K$52K$26K$321K
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms